Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 11.89x is 31% above its estimated 2-year average of 9.06x, around the middle of its estimated 2-year range (5.08x–15.04x).
As of 2026-10-06T15:37:18.602Z. 18.04% above its estimated 12-month average of 10.07x.
Calculation as of: 2026-10-06T15:37:18.602Z.
Quote observation: 2026-10-06T15:35:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 19f1946388931e4ee5326c5171249fc23a65b0c9e42408d49e268755c1a57655
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
11.89x
EV/SALES RATIO AVG TTM
10.07x
EV/SALES RATIO AVG 3Y
9.06x
EV/SALES RATIO AVG 5Y
9.06x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+18.04%
CURRENT VS 3Y AVG
+31.29%
CURRENT VS 5Y AVG
+31.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 447 covered companies
CURRENT VS SECTOR MEDIAN
+183.10%
vs the sector median at left
Kura Oncology, Inc.
Market Cap
$963.61M
EV/Sales Ratio
11.89x
TTM Avg
10.07x
3Y Avg
9.06x
5Y Avg
9.06x
Market Cap
$950.49M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$947.18M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$990.99M
EV/Sales Ratio
1.60x
TTM Avg
1.77x
3Y Avg
2.17x
5Y Avg
3.33x
Market Cap
$993.22M
EV/Sales Ratio
91.65x
TTM Avg
120.79x
3Y Avg
120.79x
5Y Avg
120.79x
Market Cap
$997.80M
EV/Sales Ratio
2.43x
TTM Avg
16.24x
3Y Avg
25.95x
5Y Avg
23.23x
Market Cap
$998.93M
EV/Sales Ratio
2.52x
TTM Avg
4.19x
3Y Avg
12.20x
5Y Avg
19.04x
Market Cap
$1.00B
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $963.61M | 11.89x | 10.07x | 9.06x | 9.06x |
| MoonLake Immunotherapeutics (MLTX)vs › | $950.49M | N/A | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $947.18M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $990.99M | 1.60x | 1.77x | 2.17x | 3.33x |
| CeriBell, Inc. (CBLL)vs › | $933.43M | 9.05x | 7.82x | 8.63x | 8.63x |
| Aktis Oncology, Inc. (AKTS)vs › | $993.22M | 91.65x | 120.79x | 120.79x | 120.79x |
| MeiraGTx Holdings plc (MGTX)vs › | $997.80M | 2.43x | 16.24x | 25.95x | 23.23x |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $998.93M | 2.52x | 4.19x | 12.20x | 19.04x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 11.63x |
| 2026-10-02 | 11.66x |
| 2026-10-01 | 11.66x |
| 2026-09-30 | 11.73x |
| 2026-09-29 | 11.85x |
| 2026-09-28 | 11.61x |
| 2026-09-25 | 11.79x |
| 2026-09-24 | 11.90x |
| 2026-09-23 | 12.11x |
| 2026-09-22 | 12.90x |
| 2026-09-21 | 12.75x |
| 2026-09-18 | 12.90x |
| 2026-09-17 | 12.89x |
| 2026-09-16 | 12.29x |
| 2026-09-15 | 12.41x |
| 2026-09-14 | 12.71x |
| 2026-09-11 | 12.51x |
| 2026-09-10 | 12.72x |
| 2026-09-09 | 13.32x |
| 2026-09-08 | 13.81x |
| 2026-09-04 | 14.65x |
| 2026-09-03 | 14.54x |
| 2026-09-02 | 14.49x |
| 2026-09-01 | 14.24x |
| 2026-08-31 | 13.96x |
| 2026-08-28 | 13.97x |
| 2026-08-27 | 14.57x |
| 2026-08-26 | 14.43x |
| 2026-08-25 | 15.04x |
| 2026-08-24 | 13.67x |
| 2026-08-21 | 13.09x |
| 2026-08-20 | 12.88x |
| 2026-08-19 | 13.82x |
| 2026-08-18 | 13.59x |
| 2026-08-17 | 12.39x |
| 2026-08-14 | 11.90x |
| 2026-08-13 | 11.02x |
| 2026-08-12 | 12.09x |
| 2026-08-11 | 12.08x |
| 2026-08-10 | 11.98x |
| 2026-08-07 | 11.63x |
| 2026-08-06 | 11.27x |
| 2026-08-05 | 11.17x |
| 2026-08-04 | 11.51x |
| 2026-08-03 | 11.16x |
| 2026-07-31 | 10.94x |
| 2026-07-30 | 11.31x |
| 2026-07-29 | 10.84x |
| 2026-07-28 | 11.31x |
| 2026-07-27 | 12.35x |
| 2026-07-24 | 12.64x |
| 2026-07-23 | 12.72x |
| 2026-07-22 | 12.83x |
| 2026-07-21 | 13.26x |
| 2026-07-20 | 13.00x |
| 2026-07-17 | 13.23x |
| 2026-07-16 | 13.26x |
| 2026-07-15 | 13.81x |
| 2026-07-14 | 13.70x |
| 2026-07-13 | 13.29x |
| 2026-07-10 | 13.96x |
| 2026-07-09 | 14.73x |
| 2026-07-08 | 14.78x |
| 2026-07-07 | 14.62x |
| 2026-07-06 | 13.45x |
| 2026-07-02 | 13.52x |
| 2026-07-01 | 13.13x |
| 2026-06-30 | 13.36x |
| 2026-06-29 | 13.36x |
| 2026-06-26 | 13.28x |
| 2026-06-25 | 12.61x |
| 2026-06-24 | 12.93x |
| 2026-06-23 | 12.63x |
| 2026-06-22 | 12.61x |
| 2026-06-18 | 12.08x |
| 2026-06-17 | 11.63x |
| 2026-06-16 | 11.42x |
| 2026-06-15 | 11.59x |
| 2026-06-12 | 10.99x |
| 2026-06-11 | 10.75x |
| 2026-06-10 | 10.53x |
| 2026-06-09 | 10.69x |
| 2026-06-08 | 10.38x |
| 2026-06-05 | 10.60x |
| 2026-06-04 | 10.64x |
| 2026-06-03 | 10.49x |
| 2026-06-02 | 10.89x |
| 2026-06-01 | 10.97x |
| 2026-05-29 | 12.41x |
| 2026-05-28 | 12.13x |
| 2026-05-27 | 12.46x |
| 2026-05-26 | 12.67x |
| 2026-05-22 | 13.71x |
| 2026-05-21 | 13.56x |
| 2026-05-20 | 12.58x |
| 2026-05-19 | 10.88x |
| 2026-05-18 | 11.17x |
| 2026-05-15 | 11.20x |
| 2026-05-14 | 11.84x |
| 2026-05-13 | 11.52x |
| 2026-05-12 | 10.72x |
| 2026-05-11 | 10.50x |
| 2026-05-08 | 10.38x |
| 2026-05-07 | 10.25x |
| 2026-05-06 | 10.57x |
| 2026-05-05 | 10.22x |
| 2026-05-04 | 10.16x |
| 2026-05-01 | 9.54x |
| 2026-04-30 | 9.62x |
| 2026-04-29 | 9.51x |
| 2026-04-28 | 9.62x |
| 2026-04-27 | 9.93x |
| 2026-04-24 | 10.18x |
| 2026-04-23 | 10.19x |
| 2026-04-22 | 10.53x |
| 2026-04-21 | 10.45x |
| 2026-04-20 | 10.85x |
| 2026-04-17 | 10.72x |
| 2026-04-16 | 9.76x |
| 2026-04-15 | 9.90x |
| 2026-04-14 | 10.02x |
| 2026-04-13 | 9.47x |
| 2026-04-10 | 9.41x |
| 2026-04-09 | 9.64x |
| 2026-04-08 | 9.56x |
| 2026-04-07 | 9.60x |
| 2026-04-06 | 9.17x |
| 2026-04-02 | 9.33x |
| 2026-04-01 | 8.98x |
| 2026-03-31 | 8.70x |
| 2026-03-30 | 8.18x |
| 2026-03-27 | 8.19x |
| 2026-03-26 | 9.00x |
| 2026-03-25 | 9.25x |
| 2026-03-24 | 8.62x |
| 2026-03-23 | 8.95x |
| 2026-03-20 | 8.87x |
| 2026-03-19 | 9.09x |
| 2026-03-18 | 9.04x |
| 2026-03-17 | 9.29x |
| 2026-03-16 | 9.48x |
| 2026-03-13 | 9.38x |
| 2026-03-12 | 9.63x |
| 2026-03-11 | 10.12x |
| 2026-03-10 | 10.18x |
| 2026-03-09 | 10.35x |
| 2026-03-06 | 9.78x |
| 2026-03-05 | 6.44x |
| 2026-03-04 | 6.47x |
| 2026-03-03 | 6.43x |
| 2026-03-02 | 6.58x |
| 2026-02-27 | 6.63x |
| 2026-02-26 | 6.56x |
| 2026-02-25 | 6.48x |
| 2026-02-24 | 6.33x |
| 2026-02-23 | 6.31x |
| 2026-02-20 | 6.40x |
| 2026-02-19 | 6.50x |
| 2026-02-18 | 6.42x |
| 2026-02-17 | 6.42x |
| 2026-02-13 | 6.27x |
| 2026-02-12 | 6.03x |
| 2026-02-11 | 5.88x |
| 2026-02-10 | 5.88x |
| 2026-02-09 | 5.82x |
| 2026-02-06 | 5.87x |
| 2026-02-05 | 5.51x |
| 2026-02-04 | 6.07x |
| 2026-02-03 | 6.20x |
| 2026-02-02 | 6.24x |
| 2026-01-30 | 6.11x |
| 2026-01-29 | 6.20x |
| 2026-01-28 | 6.04x |
| 2026-01-27 | 6.41x |
| 2026-01-26 | 6.49x |
| 2026-01-23 | 6.54x |
| 2026-01-22 | 6.93x |
| 2026-01-21 | 6.62x |
| 2026-01-20 | 6.52x |
| 2026-01-16 | 6.40x |
| 2026-01-15 | 6.78x |
| 2026-01-14 | 7.16x |
| 2026-01-13 | 7.03x |
| 2026-01-12 | 7.00x |
| 2026-01-09 | 7.20x |
| 2026-01-08 | 7.32x |
| 2026-01-07 | 7.67x |
| 2026-01-06 | 7.31x |
| 2026-01-05 | 7.31x |
| 2026-01-02 | 7.98x |
| 2025-12-31 | 8.02x |
| 2025-12-30 | 7.88x |
| 2025-12-29 | 8.08x |
| 2025-12-26 | 8.23x |
| 2025-12-24 | 8.59x |
| 2025-12-23 | 8.36x |
| 2025-12-22 | 8.77x |
| 2025-12-19 | 7.56x |
| 2025-12-18 | 7.57x |
| 2025-12-17 | 7.85x |
| 2025-12-16 | 8.23x |
| 2025-12-15 | 8.17x |
| 2025-12-12 | 7.88x |
| 2025-12-11 | 8.08x |
| 2025-12-10 | 8.32x |
| 2025-12-09 | 8.26x |
| 2025-12-08 | 9.08x |
| 2025-12-05 | 9.34x |
| 2025-12-04 | 9.36x |
| 2025-12-03 | 9.36x |
| 2025-12-02 | 8.65x |
| 2025-12-01 | 8.91x |
| 2025-11-28 | 9.50x |
| 2025-11-26 | 9.37x |
| 2025-11-25 | 9.04x |
| 2025-11-24 | 9.15x |
| 2025-11-21 | 8.68x |
| 2025-11-20 | 8.52x |
| 2025-11-19 | 8.81x |
| 2025-11-18 | 8.61x |
| 2025-11-17 | 8.41x |
| 2025-11-14 | 8.72x |
| 2025-11-13 | 8.27x |
| 2025-11-12 | 8.27x |
| 2025-11-11 | 8.28x |
| 2025-11-10 | 7.97x |
| 2025-11-07 | 7.58x |
| 2025-11-06 | 7.83x |
| 2025-11-05 | 7.65x |
| 2025-11-04 | 9.72x |
| 2025-11-03 | 9.53x |
| 2025-10-31 | 10.05x |
| 2025-10-30 | 10.23x |
| 2025-10-29 | 10.04x |
| 2025-10-28 | 10.30x |
| 2025-10-27 | 10.86x |
| 2025-10-24 | 9.45x |
| 2025-10-23 | 8.82x |
| 2025-10-22 | 9.01x |
| 2025-10-21 | 9.33x |
| 2025-10-20 | 9.76x |
| 2025-10-17 | 9.60x |
| 2025-10-16 | 9.90x |
| 2025-10-15 | 10.07x |
| 2025-10-14 | 9.37x |
| 2025-10-13 | 9.69x |
| 2025-10-10 | 9.61x |
| 2025-10-09 | 10.03x |
| 2025-10-08 | 9.85x |
| 2025-10-07 | 9.17x |
| 2025-10-06 | 9.56x |
| 2025-10-03 | 9.31x |
| 2025-10-02 | 8.86x |
| 2025-10-01 | 8.93x |
| 2025-09-30 | 8.56x |
| 2025-09-29 | 8.68x |
| 2025-09-26 | 8.77x |
| 2025-09-25 | 8.04x |
| 2025-09-24 | 8.06x |
| 2025-09-23 | 7.92x |
Showing the most recent 260 of 647 data points. The chart above shows the full history.
